ReoPro (abciximab) to inhibit blood clotting

January 1996

You'll see more cardiologists using ReoPro (abciximab) to inhibit blood clotting.

This biotech anti-platelet drug came out earlier this year. It's for patients undergoing balloon angioplasty...to help keep the dilated artery open.

So far it's only approved for high-risk patients. But now there's evidence of an overwhelming benefit in reducing MI and death...even after routine cases of angioplasty.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote